WARSAW, Poland – Poland plans to go ahead with immunizations using the Johnson & Johnson vaccine after receiving its first batch of 120,000 doses on Wednesday.
Health Minister Adam Niedzielski said Poland is following the latest recommendations from the European Medicines Agency, which said it is “currently not clear” whether the J&J shot caused rare blood clots reported in some recipients. The EMA approved the vaccine for use in the European Union last month.
“In line with these recommendations, we will want to use it in inoculations,” Niedzielski said.
The Food and Drug Administration on Tuesday temporarily paused Johnson & Johnson shots in the United States to investigate possible links to blood clots in six women six to 13 days after vaccination.
Poland is trying to speed up its vaccination drive amid high numbers of daily coronavirus cases and COVID-19-related deaths. Niedzielski said some 75% of COVID-19 hospital beds are taken.
The country of some 38 million people has administered almost 8 million doses of the Pfizer, Moderna and AstraZeneca vaccines.